High p27Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin.

High p27Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin.

Item
http://www.wikidata.org/entity/Q44598284
p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapyPathways to tamoxifen resistance.Regulation of hormonal therapy resistance by cell cycle machinery.p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies.Hunk is required for HER2/neu-induced mammary tumorigenesis.Loss of p27KIP1 expression in fully-staged node-negative breast cancer: association with lack of hormone receptors in T1a/b, but not T1c infiltrative ductal carcinoma.Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.Genes related to suppression of malignant phenotype induced by Maitake D-Fraction in breast cancer cells.Endocrine dysfunction in p27Kip1 deficient mice and susceptibility to Wnt-1 driven breast cancerp27(Kip1) as a prognostic factor in breast cancer: a systematic review and meta-analysisCyclin-dependent kinase inhibitor p27 as a prognostic biomarker and potential cancer therapeutic target.The novel role of miRNAs for tamoxifen resistance in human breast cancer.Cell cycle dysregulation influences survival in high risk breast cancer patients.Biofunctional characteristics of in situ and invasive breast carcinoma.PRO_10 – A New Tissue-Based Prognostic Multigene Marker in Patients with Early Estrogen Receptor-Positive Breast Cancer
P2860

High p27Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin.

Item
http://www.wikidata.org/entity/Q44598284
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
High p27Kip1 expression predic ...... with tamoxifen plus goserelin.
@en
High p27Kip1 expression predic ...... with tamoxifen plus goserelin.
@nl
type
label
High p27Kip1 expression predic ...... with tamoxifen plus goserelin.
@en
High p27Kip1 expression predic ...... with tamoxifen plus goserelin.
@nl
prefLabel
High p27Kip1 expression predic ...... with tamoxifen plus goserelin.
@en
High p27Kip1 expression predic ...... with tamoxifen plus goserelin.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
High p27Kip1 expression predic ...... with tamoxifen plus goserelin.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698